Moya Torrecilla, F.; Álvarez-Corral, G.; Gutiérrez Pérez, E.; Morell-Garcia, D.; Ortega Pérez, J.; Rodríguez, B.M.; Sánchez Martín, L.; Temboury Ruiz, F.
Budget Impact Analysis of the Use of Specific Biomarkers GFAP and UCH-L1 in the Management of Mild Traumatic Brain Injury in Spain. J. Clin. Med. 2025, 14, 4095.
https://doi.org/10.3390/jcm14124095
AMA Style
Moya Torrecilla F, Álvarez-Corral G, Gutiérrez Pérez E, Morell-Garcia D, Ortega Pérez J, Rodríguez BM, Sánchez Martín L, Temboury Ruiz F.
Budget Impact Analysis of the Use of Specific Biomarkers GFAP and UCH-L1 in the Management of Mild Traumatic Brain Injury in Spain. Journal of Clinical Medicine. 2025; 14(12):4095.
https://doi.org/10.3390/jcm14124095
Chicago/Turabian Style
Moya Torrecilla, Francisco, Gemma Álvarez-Corral, Eva Gutiérrez Pérez, Daniel Morell-Garcia, Juan Ortega Pérez, Beatriz Miriam Rodríguez, Leticia Sánchez Martín, and Francisco Temboury Ruiz.
2025. "Budget Impact Analysis of the Use of Specific Biomarkers GFAP and UCH-L1 in the Management of Mild Traumatic Brain Injury in Spain" Journal of Clinical Medicine 14, no. 12: 4095.
https://doi.org/10.3390/jcm14124095
APA Style
Moya Torrecilla, F., Álvarez-Corral, G., Gutiérrez Pérez, E., Morell-Garcia, D., Ortega Pérez, J., Rodríguez, B. M., Sánchez Martín, L., & Temboury Ruiz, F.
(2025). Budget Impact Analysis of the Use of Specific Biomarkers GFAP and UCH-L1 in the Management of Mild Traumatic Brain Injury in Spain. Journal of Clinical Medicine, 14(12), 4095.
https://doi.org/10.3390/jcm14124095
